James Arthur Bristol, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 46,882 shares at $53.35 ($2.5M) on 2020-10-09, disclosed to the SEC on 2020-10-13.
Open-market sale of $2.5M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.35 | 19,370 | $1.0M | 41.2% |
| 2 | $53.35 | 19,370 | $1.0M | 41.2% |
| 3 | $54.53 | 3,971 | $217K | 8.6% |
| 4 | $54.53 | 3,971 | $217K | 8.6% |
| 5 | $55.43 | 200 | $11K | 0.4% |
| Total | $53.56 avg | 46,882 |
| $2.5M |
| 100% |
| Filing → |
| DCPH | SELL | 2021-04-14 | $1.3M | — | Filing → |
| DCPH | SELL | 2021-01-20 | $352K | — | Filing → |
| DCPH | SELL | 2020-07-13 | $2.6M | — | Filing → |